USE OF BIOLOGICAL DMARDS, BUT NOT OF CONVENTIONAL SYNTHETIC DMARDS OR STEROIDS, MAY BE RELEVANT TO INCREASED ENERGY INTAKE IN PATIENTS WITH RHEUMATOID ARTHRITIS

被引:0
|
作者
Masuko, K. [1 ,2 ]
Mizukami, Y. [3 ]
Tohma, S. [4 ]
Matsui, T. [5 ]
机构
[1] Int Univ Hlth & Welf, Clin Res Ctr Med, Tokyo, Japan
[2] Sanno Med Ctr, Hlth Evaluat & Promot Ctr, Tokyo, Japan
[3] Sagami Womens Univ, Grad Sch Nutr Sci, Sagamihara, Kanagawa, Japan
[4] Natl Hosp Org, Sagamihara Natl Hosp, Clin Res Ctr Allergy & Rheumatol, Sagamihara, Kanagawa, Japan
[5] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Tokyo, Japan
关键词
D O I
10.1136/annrheumdis-2017-eular.4603
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
AB0333
引用
收藏
页码:1165 / 1165
页数:1
相关论文
共 50 条
  • [1] COMPARISON OF TOFACITINIB SAFETY AND EFFICACY IN RHEUMATOID ARTHRITIS PATIENTS WITH INADEQUATE RESPONSE TO CONVENTIONAL SYNTHETIC DMARDS, OR TO ONE OR MORE BIOLOGICAL DMARDS
    Charles-Schoeman, C.
    Kremer, J.
    Krishnaswami, S.
    Soma, K.
    Geier, J.
    Zhang, R.
    Strengholt, S.
    Burmester, G.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 271 - 272
  • [2] ADVERSE EVENTS RELATED TO CONVENTIONAL SYNTHETIC DMARDS IN PATIENTS WITH RHEUMATOID ARTHRITIS
    Rojas-Zuleta, Wilmer
    Becerra-Arias, Carolina
    Donado, Jorge
    Duque-Zapata, Natalia
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2023, 29 : S80 - S81
  • [3] Efficacy and safety of baricitinib in patients with rheumatoid arthritis and inadequate response to conventional synthetic DMARDs and/or biological DMARDs: Data from a local registry
    Rosas, Jose
    Senabre-Gallego, Jose Miguel
    Santos-Soler, Gregorio
    Bernal, Jose Antonio
    Bas, Ana Pons
    REUMATOLOGIA CLINICA, 2022, 18 (03): : 188 - 189
  • [4] Regulatory T cell frequencies in patients with rheumatoid arthritis are increased by conventional and biological DMARDs but not by JAK inhibitors
    Meyer, Anja
    Wittekind, Paula S.
    Kotschenreuther, Konstantin
    Schiller, Joanna
    von Tresckow, Julia
    Haak, Thomas H.
    Kofler, David M.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 (12)
  • [5] PREDICTION OF TREATMENT DISCONTINUATION DUE TO ADVERSE EVENTS IN PATIENTS WITH RHEUMATOID ARTHRITIS USED BIOLOGICAL DMARDS AND TARGETED SYNTHETIC DMARDS
    Koltsova, E.
    Lukina, G.
    Shmidt, E.
    Lytkina, K.
    Zhilyaev, E.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 1211 - 1211
  • [6] USE OF CONVENTIONAL SYNTHETIC DMARDS AND BIOLOGICAL DMARDS IN PATIENTS WITH ENTEROPATHIC SPONDYLOARTHRITIS: A COMBINED GASTRO-RHEUMATOLOGICAL APPROACH
    Chimenti, M. S.
    Conigliaro, P.
    Triggianese, P.
    Canofari, C.
    Cedola, F.
    Onali, S.
    Calabrese, E.
    Petruzziello, C.
    Ruffa, A.
    Monteleone, G.
    Biancone, L.
    Perricone, R.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 996 - 997
  • [7] COMPARISON OF IMMUNOREGULATORY WITH CONVENTIONAL DMARDS THERAPY IN PATIENTS WITH RHEUMATOID ARTHRITIS
    Guo, Qiao Ling
    Chen, Li Bao
    Li Zhao-Hua
    Wang, Yan Yan
    Wang, Xin
    Gao, Chong
    Li Xiaofeng
    Wang, Caihong
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 1073 - 1074
  • [8] Effects of biological and targeted synthetic DMARDs on bone loss in rheumatoid arthritis
    Orsolini, Giovanni
    Fassio, Angelo
    Rossini, Maurizio
    Adami, Giovanni
    Giollo, Alessandro
    Caimmi, Cristian
    Idolazzi, Luca
    Viapiana, Ombretta
    Gatti, Davide
    PHARMACOLOGICAL RESEARCH, 2019, 147
  • [9] Cardiovascular Disease Risk with Biologics and Tofacitinib Compared to Conventional Synthetic Dmards in Patients with Rheumatoid Arthritis
    Ozen, Gulsen
    Pedro, Sofia
    Michaud, Kaleb
    ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [10] CORRELATIONS BETWEEN SYSTEMIC THERAPY WITH CONVENTIONAL (SYNTHETIC) AND BIOLOGICAL DMARDS, RHEUMATOID ARTHRITIS AND PERIODONTAL INDICES OF CHRONIC PERIODONTITIS
    Martu, Maria Alexandra
    Rezus, Elena
    Popa, Cristina
    Solomon, Sorina Mihaela
    Luchian, Ionut
    Pendefunda, Arina Ciocan
    Sioustis, Ioana
    Anton, Diana
    Martu, Silvia
    Foia, Liliana
    ROMANIAN JOURNAL OF ORAL REHABILITATION, 2018, 10 (04): : 161 - 169